Jullien V - Search Results

1

Usefulness of Therapeutic Drug Monitoring to Manage Clindamycin-Rifampicin Interaction in a Patient with Diabetic Foot Osteomyelitis.

Magréault S, Charbit J, Berkane N, Jaureguy F, Carbonnelle E, Cosson E, Jullien V, Bihan H. Magréault S, et al. Among authors: jullien v. Ther Drug Monit. 2023 Oct 1;45(5):703-706. doi: 10.1097/FTD.0000000000001123. Epub 2023 Aug 1. Ther Drug Monit. 2023. PMID: 37559218 No abstract available.

2

From Bed to Bench: Pre-analytical Stability of 29 Anti-infective Agents in Plasma and Whole Blood to Improve Accuracy of Therapeutic Drug Monitoring.

Magreault S, Pierredon D, Akinotcho-Relouzat J, Méchaï F, Lamy B, Jaureguy F, Jullien V. Magreault S, et al. Among authors: jullien v. Ther Drug Monit. 2024 Jul 2. doi: 10.1097/FTD.0000000000001237. Online ahead of print. Ther Drug Monit. 2024. PMID: 38953703

3

Inoculum effect of cefiderocol against NDM-1 producing Escherichia coli in vitro and in a murine model of peritonitis.

Godron AS, Amoura A, Pistien C, Birgy A, Magreault S, Jousset AB, Jullien V, Lefort A, Fantin B, El Meouche I, de Lastours V. Godron AS, et al. Among authors: jullien v. J Antimicrob Chemother. 2024 Dec 2;79(12):3323-3331. doi: 10.1093/jac/dkae368. J Antimicrob Chemother. 2024. PMID: 39436765

4

Improving pharmacokinetic/pharmacodynamic outcomes of antimicrobial therapy for pneumonia in the ICU.

Thy M, Magréault S, Zahar JR, Jullien V, Timsit JF. Thy M, et al. Among authors: jullien v. Expert Opin Pharmacother. 2024 Dec;25(18):2347-2365. doi: 10.1080/14656566.2024.2432478. Epub 2024 Dec 3. Expert Opin Pharmacother. 2024. PMID: 39587056 Review.

5

Impact of the inoculum size on the in vivo activity of the aztreonam-avibactam combination in a murine model of peritonitis due to Escherichia coli expressing CTX-M-15 and NDM-1.

Amoura A, Benchetrit L, Magréault S, Chosidow S, Le Menestrel A, Jullien V, de Lastours V, Chau F, Dion S, Massias L, Fantin B, Lefort A. Amoura A, et al. Among authors: jullien v. Antimicrob Agents Chemother. 2024 Dec 19:e0128822. doi: 10.1128/aac.01288-22. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 39699211 Free article.

6

Caspofungin sequestration in a polyacrylonitrile-derived filter: Increasing the dose does not mitigate sequestration.

Baud FJ, Jullien V, Desnos-Ollivier M, Lamhaut L, Lortholary O. Baud FJ, et al. Among authors: jullien v. Int J Antimicrob Agents. 2023 Dec;62(6):107007. doi: 10.1016/j.ijantimicag.2023.107007. Epub 2023 Oct 13. Int J Antimicrob Agents. 2023. PMID: 37839719

7

Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study.

Goutelle S, Jullien V, Bru JP, Cattoir V, Gauzit R, Lesprit P, Lina G, Schramm F, Canoui E, Lepeule R. Goutelle S, et al. Among authors: jullien v. J Antimicrob Chemother. 2023 Nov 6;78(11):2762-2769. doi: 10.1093/jac/dkad300. J Antimicrob Chemother. 2023. PMID: 37796958 Free article.

8

A modified position for optimized skeletal maturity assessment of AIS patients and its impact on 3D spinal and pelvic parameters.

Blouin V, Jullien V, Chémaly O, Roy-Beaudry M, Deschênes S, Barchi S, Nault ML, Flynn JM, Parent S. Blouin V, et al. Among authors: jullien v. Spine Deform. 2024 Nov;12(6):1639-1645. doi: 10.1007/s43390-024-00903-1. Epub 2024 May 31. Spine Deform. 2024. PMID: 38819535 Clinical Trial.

9

What clindamycin dose should be administered by continuous infusion during combination therapy with rifampicin? A prospective population pharmacokinetics study.

Mimram L, Magréault S, Kerroumi Y, Salmon D, Kably B, Marmor S, Jannot AS, Jullien V, Zeller V. Mimram L, et al. Among authors: jullien v. J Antimicrob Chemother. 2023 Dec 1;78(12):2943-2949. doi: 10.1093/jac/dkad335. J Antimicrob Chemother. 2023. PMID: 37883695

10

Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.

Goulenok T, Seurat J, Selle A, Jullien V, Leflon-Guibout V, Grall N, Lescure FX, Lepeule R, Bertrand J, Fantin B, Burdet C, Lefort A. Goulenok T, et al. Among authors: jullien v. Int J Antimicrob Agents. 2023 Aug;62(2):106885. doi: 10.1016/j.ijantimicag.2023.106885. Epub 2023 Jun 10. Int J Antimicrob Agents. 2023. PMID: 37302771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters